Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander P Ruggieri

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Health Care Financing Review|August 5, 2003
From clinical records to regulatory reporting: formal terminologies as foundationMarcelline R Harris, Alexander P Ruggieri, Christopher G Chute
Studies in Health Technology and Informatics|September 14, 2004
A corpus driven approach applying the "frame semantic" method for modeling functional status terminologyAlexander P Ruggieri, Serguei V Pakhomov, Christopher G Chute
Journal of Managed Care & Specialty Pharmacy|June 26, 2015
Intravenous Versus Subcutaneous Anti-TNF-Alpha Agents for Crohn's Disease: A Comparison of Effectiveness and SafetyJinan Liu, Gosia Sylwestrzak, Alexander P Ruggieri, et al.
American Health & Drug Benefits|July 4, 2014
Considering patient preferences when selecting anti-tumor necrosis factor therapeutic optionsGosia Sylwestrzak, Jinan Liu, Judith J Stephenson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Health Care Financing Review|August 5, 2003
From clinical records to regulatory reporting: formal terminologies as foundationMarcelline R Harris, Alexander P Ruggieri, Christopher G Chute
Studies in Health Technology and Informatics|September 14, 2004
A corpus driven approach applying the "frame semantic" method for modeling functional status terminologyAlexander P Ruggieri, Serguei V Pakhomov, Christopher G Chute
Journal of Managed Care & Specialty Pharmacy|June 26, 2015
Intravenous Versus Subcutaneous Anti-TNF-Alpha Agents for Crohn's Disease: A Comparison of Effectiveness and SafetyJinan Liu, Gosia Sylwestrzak, Alexander P Ruggieri, et al.
American Health & Drug Benefits|July 4, 2014
Considering patient preferences when selecting anti-tumor necrosis factor therapeutic optionsGosia Sylwestrzak, Jinan Liu, Judith J Stephenson, et al.
Pageof 1